Assignee
HISTIDE AG
CH·1 granted patent·11 pending applications·0 citations·filing 2016–2023
Top patents by PatentIndex Score
12 records- 0150US2025388633A1Pharmaceutical association of growth factor receptor agonist and adhesion protein inhibitor for converting a neoplastic cell into a non-neoplastic cell and uses thereofHISTIDE AG·Filed 2023·Application pending·0 cites
- 0247US2023322878A1Compounds for inducing tissue formation and uses thereofHISTIDE AG·Filed 2023·Application pending·0 cites
- 0342US2022273759A1Pharmaceutical association for converting a neoplastic cell into a non-neoplastic cell and uses thereofHISTIDE AG·Filed 2022·Application pending·0 cites
- 0440US2022267394A1Compounds for inducing tissue formation and uses thereofHISTIDE AG·Filed 2021·Application pending·0 cites
- 0533US11578110B2Compounds for inducing tissue formation and uses thereofHISTIDE AG·Filed 2016·Granted Feb 14, 2023·0 cites·14 claims
- 0630US2019374600A1Pharmaceutical association comprising a growth factor receptor agonist conjugated to a bioactive carrier for converting a neoplastic cell into a non-neoplastic cell and uses thereofHISTIDE AG·Filed 2016·Application pending·0 cites
- 0730US2019330290A1Pharmaceutical association of growth factor receptor agonist and adhesion protein inhibitor for converting a neoplastic cell into a non-neoplastic cell and uses thereofHISTIDE AG·Filed 2016·Application pending·0 cites
- 0821US2019016770A1Compounds for inducing tissue formation and uses thereofHISTIDE AG·Filed 2016·Application pending·0 cites
- 0919US2018305408A1Compounds for inducing tissue formation and uses thereofHISTIDE AG·Filed 2016·Application pending·0 cites
- 1019US2019224279A1Pharmaceutical association comprising a growth factor receptor agonist conjugated to a bioactive carrier for converting a neoplastic cell into a non-neoplastic cell and uses thereofHISTIDE AG·Filed 2016·Application pending·0 cites
- 1117US2019225651A1Compounds for inducing tissue formation and uses thereofHISTIDE AG·Filed 2016·Application pending·0 cites
- 1214US2019290729A1Pharmaceutical association of growth factor receptor agonist and adhesion protein inhibitor for converting a neoplastic cell into a non-neoplastic cell and uses thereofHISTIDE AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HISTIDE AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →